Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ).
Modern Chinese Medicine Group Co. Ltd. has called its 2026 annual general meeting for 29 May 2026 in Shijiazhuang, Hebei Province, where shareholders will review the audited consolidated financial statements and the reports of the board and auditor for the year ended 31 December 2025. The agenda also includes re-election of executive director Sun Xinlei and independent non-executive director Liu Ling, authorization for the board to set directors’ and auditor’s remuneration, re-appointment of Forvis Mazars CPA Limited as auditor, and the renewal of mandates allowing the board to repurchase up to 10% of issued shares and to issue new shares, reinforcing its capital management flexibility and corporate governance framework.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co. Ltd. is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. The group operates in the pharmaceutical and healthcare sector with a focus on modern Chinese medicine products and related services, targeting the mainland China market from its operational base in Hebei Province.
Average Trading Volume: 3,133,571
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.76B
Learn more about 1643 stock on TipRanks’ Stock Analysis page.